Position in KOD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,725,732
+$1,061,553 QoQ
Shares Held
71,504
+20.1% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KOD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $408,627,656 across 136 Biotechnology names. KOD ranks #59 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in KOD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,725,732 | 71,504 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,664,179 | 59,520 | Shares | Sole | 2026-02-13 | |
| 2021-12-31 | $5,404,979 | 63,753 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,102,457 | 32,324 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,900,763 | 31,191 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,975,353 | 26,240 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,088,603 | 7,410 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,619,452 | 27,351 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $637,858 | 11,786 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||